1 Markets
1.1 Product Definition
1.1.1 Product Definition
1.1.2 Inclusion and Exclusion Criteria
1.2 Market Scope
1.2.1 Key Questions Answered in the Report
1.3 Research Methodology
1.3.1 Cell and Gene Therapy Manufacturing QC Market
1.3.2 Data Sources
1.3.2.1 Primary Data Sources
1.3.2.2 Secondary Data Sources
1.3.3 Market Estimation Model
1.3.4 Criteria for Company Profiling
1.4 Market Overview
1.4.1 Market Scenario
1.4.1.1 Realistic Growth Scenario
1.4.1.2 Optimistic Scenario
1.4.1.3 Pessimistic Scenario
1.4.2 Market Footprint and Growth Potential
1.4.3 Future Potential
1.4.4 COVID-19 Impact on Market
1.4.4.1 Impact on Research and Clinical Operations
1.4.4.2 COVID-19 Impact: Current Scenario of the Market
1.4.4.3 Pre- and Post-COVID-19 Impact Assessment
1.4.4.3.1 Pre-COVID-19 Phase
1.4.4.3.2 Post-COVID-19 Phase
2 Cell and Gene Therapy Manufacturing QC Market: Industry Analysis
2.1 Regulatory Framework
2.1.1 Chemistry, Manufacturing, and Control (CMC) Requirements by the Food and Drug Administration (FDA)
2.1.1.1 Product Testing
2.1.1.2 Microbial Testing
2.1.1.3 Identity
2.1.1.4 Purity
2.1.1.5 Potency
2.1.1.6 Viability
2.1.1.7 Cell Number or Dose
2.1.2 Quality Aspects of Cell and Gene Therapy Products by the European Medicines Agency (EMA)
2.1.2.1 Characterization
2.1.2.2 Identity Testing
2.1.2.3 Purity Testing
2.1.3 Current Good Manufacturing Practice (CGMP) Regulations
2.1.4 Regulatory Framework: Cell and Gene Therapy Manufacturing QC Market
3 Cell and Gene Therapy Manufacturing QC Market (by Region)
3.1 Overview
3.2 Asia-Pacific
3.2.1.1 Asia-Pacific Cell and Gene Therapy Manufacturing QC Market (by Offering)
3.2.1.2 Asia-Pacific Cell and Gene Therapy Manufacturing QC Market (by Therapy Type)
3.2.1.3 Asia-Pacific Cell and Gene Therapy Manufacturing QC Market (by Process)
3.2.1.4 Asia-Pacific Cell and Gene Therapy Manufacturing QC Market (by Technology)
3.2.1.5 Asia-Pacific Cell and Gene Therapy Manufacturing QC Market (by Application)
3.2.2 China
3.2.2.1 China Cell and Gene Therapy Manufacturing QC Market (by Offering)
3.2.2.2 China Cell and Gene Therapy Manufacturing QC Market (by Therapy Type)
3.2.2.3 China Cell and Gene Therapy Manufacturing QC Market (by Process)
3.2.2.4 China Cell and Gene Therapy Manufacturing QC Market (by Technology)
3.2.2.5 China Cell and Gene Therapy Manufacturing QC Market (by Application)
3.2.3 Japan
3.2.3.1 Japan Cell and Gene Therapy Manufacturing QC Market (by Offering)
3.2.3.2 Japan Cell and Gene Therapy Manufacturing QC Market (by Therapy Type)
3.2.3.3 Japan Cell and Gene Therapy Manufacturing QC Market (by Process)
3.2.3.4 Japan Cell and Gene Therapy Manufacturing QC Market (by Technology)
3.2.3.5 Japan Cell and Gene Therapy Manufacturing QC Market (by Application)
3.2.4 South Korea
3.2.4.1 South Korea Cell and Gene Therapy Manufacturing QC Market (by Offering)
3.2.4.2 South Korea Cell and Gene Therapy Manufacturing QC Market (by Therapy Type)
3.2.4.3 South Korea Cell and Gene Therapy Manufacturing QC Market (by Process)
3.2.4.4 South Korea Cell and Gene Therapy Manufacturing QC Market (by Technology)
3.2.4.5 South Korea Cell and Gene Therapy Manufacturing QC Market (by Application)
3.2.5 Australia
3.2.5.1 Australia Cell and Gene Therapy Manufacturing QC Market (by Offering)
3.2.5.2 Australia Cell and Gene Therapy Manufacturing QC Market (by Therapy Type)
3.2.5.3 Australia Cell and Gene Therapy Manufacturing QC Market (by Process)
3.2.5.4 Australia Cell and Gene Therapy Manufacturing QC Market (by Technology)
3.2.5.5 Australia Cell and Gene Therapy Manufacturing QC Market (by Application)
3.2.6 India
3.2.6.1 India Cell and Gene Therapy Manufacturing QC Market (by Offering)
3.2.6.2 India Cell and Gene Therapy Manufacturing QC Market (by Therapy Type)
3.2.6.3 India Cell and Gene Therapy Manufacturing QC Market (by Process)
3.2.6.4 India Cell and Gene Therapy Manufacturing QC Market (by Technology)
3.2.6.5 India Cell and Gene Therapy Manufacturing QC Market (by Application)
3.2.7 Rest-of-Asia-Pacific
3.2.7.1 Rest-of-Asia-Pacific Cell and Gene Therapy Manufacturing QC Market (by Offering)
3.2.7.2 Rest-of-Asia-Pacific Cell and Gene Therapy Manufacturing QC Market (by Therapy Type)
3.2.7.3 Rest-of-Asia-Pacific Cell and Gene Therapy Manufacturing QC Market (by Process)
3.2.7.4 Rest-of-Asia-Pacific Cell and Gene Therapy Manufacturing QC Market (by Technology)
3.2.7.5 Rest-of-Asia-Pacific Cell and Gene Therapy Manufacturing QC Market (by Application)
4 Company Profiles
4.1 Overview
4.2 Manufacturers
4.2.1 WuXi AppTec
4.2.1.1 Company Overview
4.2.1.2 Role of WuXi AppTec in the Cell and Gene Therapy Manufacturing QC Market
4.2.1.3 Key Competitors
4.2.1.4 Financials
4.2.1.5 Analyst Perspective
List of Figures
Figure 1: Asia-Pacific Cell and Gene Therapy Manufacturing QC Market, $Billion, 2022-2033
Figure 2: Asia-Pacific Cell and Gene Therapy Manufacturing QC Market, Impact Analysis
Figure 3: Asia-Pacific Cell and Gene Therapy Manufacturing QC Market (by Therapy Type), % Share, 2022 and 2033
Figure 4: Asia-Pacific Cell and Gene Therapy Manufacturing QC Market (by Offering), % Share, 2022 and 2033
Figure 5: Asia-Pacific Cell and Gene Therapy Manufacturing QC Market (by Process), % Share, 2022 and 2033
Figure 6: Asia-Pacific Cell and Gene Therapy Manufacturing QC Market (by Technology), % Share, 2022 and 2033
Figure 7: Asia-Pacific Cell and Gene Therapy Manufacturing QC Market (by Application), % Share, 2022 and 2033
Figure 8: Cell and Gene Therapy Manufacturing QC Market (by Region), Market Snapshot
Figure 9: Cell and Gene Therapy Manufacturing QC Market: Research Methodology
Figure 10: Primary Research Methodology
Figure 11: Bottom-Up Approach (Segment-Wise Analysis)
Figure 12: Top-Down Approach (Segment-Wise Analysis)
Figure 13: Asia-Pacific Cell and Gene Therapy Manufacturing QC Market Size and Growth Potential (Realistic Scenario), $Billion, 2022-2033
Figure 14: Asia-Pacific Cell and Gene Therapy Manufacturing QC Market Size and Growth Potential (Optimistic Scenario), $Billion, 2022-2033
Figure 15: Asia-Pacific Cell and Gene Therapy Manufacturing QC Market Size and Growth Potential (Pessimistic Scenario), $Billion, 2022-2033
Figure 16: Asia-Pacific Cell and Gene Therapy Manufacturing QC Market, $Billion, 2022-2033
Figure 17: Impact of COVID-19 on CGT Developmental Activities
Figure 18: Cell and Gene Therapy Manufacturing QC Market (by Region), Market Snapshot
Figure 19: Asia-Pacific Cell and Gene Therapy Manufacturing QC Market, $Million, 2022-2033
Figure 20: Asia-Pacific Cell and Gene Therapy Manufacturing QC Market (by Country), % Share, 2022-2033
Figure 21: Asia-Pacific Cell and Gene Therapy Manufacturing QC Market (by Offering), $Million, 2022-2033
Figure 22: Asia-Pacific Cell and Gene Therapy Manufacturing QC Market (by Therapy Type), $Million, 2022-2033
Figure 23: Asia-Pacific Cell and Gene Therapy Manufacturing QC Market (by Process), $Million, 2022-2033
Figure 24: Asia-Pacific Cell and Gene Therapy Manufacturing QC Market (by Technology), $Million, 2022-2033
Figure 25: Asia-Pacific Cell and Gene Therapy Manufacturing QC Market (by Application), $Million, 2022-2033
Figure 26: China Cell and Gene Therapy Manufacturing QC Market, $Million, 2022-2033
Figure 27: China Cell and Gene Therapy Manufacturing QC Market (by Offering), $Million, 2022-2033
Figure 28: China Cell and Gene Therapy Manufacturing QC Market (by Therapy Type), $Million, 2022-2033
Figure 29: China Cell and Gene Therapy Manufacturing QC Market (by Process), $Million, 2022-2033
Figure 30: China Cell and Gene Therapy Manufacturing QC Market (by Technology), $Million, 2022-2033
Figure 31: China Cell and Gene Therapy Manufacturing QC Market (by Application), $Million, 2022-2033
Figure 32: Japan Cell and Gene Therapy Manufacturing QC Market, $Million, 2022-2033
Figure 33: Japan Cell and Gene Therapy Manufacturing QC Market (by Offering), $Million, 2022-2033
Figure 34: Japan Cell and Gene Therapy Manufacturing QC Market (by Therapy Type), $Million, 2022-2033
Figure 35: Japan Cell and Gene Therapy Manufacturing QC Market (by Process), $Million, 2022-2033
Figure 36: Japan Cell and Gene Therapy Manufacturing QC Market (by Technology), $Million, 2022-2033
Figure 37: Japan Cell and Gene Therapy Manufacturing QC Market (by Application), $Million, 2022-2033
Figure 38: South Korea Cell and Gene Therapy Manufacturing QC Market, $Million, 2022-2033
Figure 39: South Korea Cell and Gene Therapy Manufacturing QC Market (by Offering), $Million, 2022-2033
Figure 40: South Korea Cell and Gene Therapy Manufacturing QC Market (by Therapy Type), $Million, 2022-2033
Figure 41: South Korea Cell and Gene Therapy Manufacturing QC Market (by Process), $Million, 2022-2033
Figure 42: South Korea Cell and Gene Therapy Manufacturing QC Market (by Technology), $Million, 2022-2033
Figure 43: South Korea Cell and Gene Therapy Manufacturing QC Market (by Application), $Million, 2022-2033
Figure 44: Australia Cell and Gene Therapy Manufacturing QC Market, $Million, 2022-2033
Figure 45: Australia Cell and Gene Therapy Manufacturing QC Market (by Offering), $Million, 2022-2033
Figure 46: Australia Cell and Gene Therapy Manufacturing QC Market (by Therapy Type), $Million, 2022-2033
Figure 47: Australia Cell and Gene Therapy Manufacturing QC Market (by Process), $Million, 2022-2033
Figure 48: Australia Cell and Gene Therapy Manufacturing QC Market (by Technology), $Million, 2022-2033
Figure 49: Australia Cell and Gene Therapy Manufacturing QC Market (by Application), $Million, 2022-2033
Figure 50: India Cell and Gene Therapy Manufacturing QC Market, $Million, 2022-2033
Figure 51: India Cell and Gene Therapy Manufacturing QC Market (by Offering), $Million, 2022-2033
Figure 52: India Cell and Gene Therapy Manufacturing QC Market (by Therapy Type), $Million, 2022-2033
Figure 53: India Cell and Gene Therapy Manufacturing QC Market (by Process), $Million, 2022-2033
Figure 54: India Cell and Gene Therapy Manufacturing QC Market (by Technology), $Million, 2022-2033
Figure 55: India Cell and Gene Therapy Manufacturing QC Market (by Application), $Million, 2022-2033
Figure 56: Rest-of-Asia-Pacific Cell and Gene Therapy Manufacturing QC Market, $Million, 2022-2033
Figure 57: Rest-of-Asia-Pacific Cell and Gene Therapy Manufacturing QC Market (by Offering), $Million, 2022-2033
Figure 58: Rest-of-Asia-Pacific Cell and Gene Therapy Manufacturing QC Market (by Therapy Type), $Million, 2022-2033
Figure 59: Rest-of-Asia-Pacific Cell and Gene Therapy Manufacturing QC Market (by Process), $Million, 2022-2033
Figure 60: Rest-of-Asia-Pacific Cell and Gene Therapy Manufacturing QC Market (by Technology), $Million, 2022-2033
Figure 61: Rest-of-Asia-Pacific Cell and Gene Therapy Manufacturing QC Market (by Application), $Million, 2022-2033
Figure 62: Total Number of Companies Profiled
Figure 63: WuXi AppTec: Product Portfolio
Figure 64: WuXi AppTec: Overall Financials, $Million, 2020-2022
Figure 65: WuXi AppTec: Revenue (by Segment), $Million, 2021 and 2022
List of Tables
Table 1: Key Questions Answered in the Report
Table 2: Regulatory Scenario: Cell and Gene Therapy Manufacturing QC Market
Table 3: Asia-Pacific Cell and Gene Therapy Manufacturing QC Market Dynamics, Impact Analysis
Table 4: Approved Cell and Gene Therapies, Japan
